![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Amyloid Neuropathies, Familial - 22 Studies Found
Completed |
: Study of SOM0226 in Familial Amyloid Polyneuropathy : Familial Amyloid Polyneuropathy (FAP) : 2014-07-09 : Drug: SOM0226 Oral |
Completed |
: Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis : Familial Amyloid Polyneuropathy : 2006-12-06 :
|
Active, not recruiting |
: Efficacy and Safety of IONIS-TTR Rx in Familial Amyloid Polyneuropathy :
|
Enrolling by invitation |
: Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP) :
|
Completed |
: An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy :
: 2008-11-13 : Drug: Fx-1006A Fx-1006A 20mg soft gelatin capsule administered orally once daily (at the same time each |
Completed |
: The Effect of Diflunisal on Familial Amyloidosis :
: 2006-02-21 :
|
Completed |
: The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant :
: Drug: Revusiran (ALN-TTRSC) 500mg Revusiran by subcutaneous (sc) injection |
Active, not recruiting |
: APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis :
|
Available |
: Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) :
|